Literature DB >> 8690461

Immunogenicity of peptides coupled with multiple T-cell epitopes of a surface protein antigen of Streptococcus mutans.

H Senpuku1, T Iizima, Y Yamaguchi, S Nagata, Y Ueno, M Saito, N Hanada, T Nisizawa.   

Abstract

A surface protein antigen (PAc) of Streptococcus mutans, in particular the A-region of the molecule, has been noted as a possible target of effective dental caries vaccine. We have previously shown that two peptides of 19 amino acids (residues 361-379, NAKATYEAALKQYEADLAA, and residues 301-319, ANAANEADYQAKLTAYQTE), which correspond to parts of the A-region, contain both T- and B-cell epitopes for the induction of cross-reacting antibodies to the PAc. In this study, for development of an appropriate antigen as a peptide vaccine for use in prophylactic dentistry, we analysed in detail the localization of the T- and B-cell epitopes of PAc(361-379) peptide and the T-cell epitope of PAc(301-319) peptide in B10 congenic mice. In four murine major histocompatibility complex (MHC) haplotypes (H-2f,d,a and k), PAc(361-377) peptide showed T- and B-cell epitopes forming a cluster. It was found that the antibody which was induced by the immunization with the peptide was strongly cross-reactive with recombinant (r)PAc. Meanwhile, PAc(305-318) peptide, recognised by five strains of mice of different MHC haplotypes (H-2f,d,a,k and s), also bore multiple T-cell epitopes. PAc(361-377) peptide coupled to PAc(305-318) significantly elevated cross-reacting antibody levels compared to immunization with PAc(361-377) only in four H-2 haplotypes. Moreover, a peptide with PAc(305-318) coupled to the N-terminal region of PAc(361-377) produced significant cross-reacting antibody against rPAc, even in B10.S mice which had not responded to immunization with PAc(361-379) peptide. Therefore, it was suggested that coupling among the peptides forming a cluster might be effective in increasing immunogenicity. These results may provide us with a useful strategy for the design of peptide-based vaccines for S. mutans in the future.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690461      PMCID: PMC1456436          DOI: 10.1111/j.1365-2567.1996.tb00015.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses.

Authors:  E B Schaeffer; A Sette; D L Johnson; M C Bekoff; J A Smith; H M Grey; S Buus
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

2.  Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c.

Authors:  M W Russell; T Lehner
Journal:  Arch Oral Biol       Date:  1978       Impact factor: 2.633

Review 3.  Biology, immunology, and cariogenicity of Streptococcus mutans.

Authors:  S Hamada; H D Slade
Journal:  Microbiol Rev       Date:  1980-06

4.  Protein antigens of Streptococcus mutans: purification and properties of a double antigen and its protease-resistant component.

Authors:  M W Russell; L A Bergmeier; E D Zanders; T Lehner
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

5.  Immunisation of monkeys (Macaca fascicularis) with antigens purified from Streptococcus mutans.

Authors:  R R Russell; D Beighton; B Cohen
Journal:  Br Dent J       Date:  1982-02-02       Impact factor: 1.626

6.  Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.

Authors:  J A Berzofsky; C D Pendleton; M Clerici; J Ahlers; D R Lucey; S D Putney; G M Shearer
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

7.  Wall-associated protein antigens of Streptococcus mutans.

Authors:  R R Russell
Journal:  J Gen Microbiol       Date:  1979-09

8.  Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries.

Authors:  T Lehner; J Caldwell; R Smith
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Characteristics of a high molecular weight extracellular protein of Streptococcus mutans.

Authors:  H Forester; N Hunter; K W Knox
Journal:  J Gen Microbiol       Date:  1983-09

10.  Use of monoclonal antibodies in local passive immunization to prevent colonization of human teeth by Streptococcus mutans.

Authors:  J K Ma; R Smith; T Lehner
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more
  6 in total

1.  Construction and in vitro expression of Streptococcus mutans surface protein encoding DNA vaccine.

Authors:  Z Peng; M Fan; Z Bian; Z Chen; B Peng
Journal:  J Tongji Med Univ       Date:  2001

2.  Induction of neutralizing antibodies in mice immunized with an amino-terminal polypeptide of Streptococcus mutans P1 protein produced by a recombinant Bacillus subtilis strain.

Authors:  Milene B Tavares; Bruno M Silva; Rafael C M Cavalcante; Renata D Souza; Wilson B Luiz; Juliano D Paccez; Paula J Crowley; L Jeannine Brady; Luís C S Ferreira; Rita C C Ferreira
Journal:  FEMS Immunol Med Microbiol       Date:  2010-03-10

3.  Identification of Streptococcus mutans PAc peptide motif binding with human MHC class II molecules (DRB1*0802, *1101, *1401 and *1405).

Authors:  H Senpuku; K Yanagi; T Nisizawa
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

4.  Molecular interactions of surface protein peptides of Streptococcus gordonii with human salivary components.

Authors:  Tomoyuki Hamada; Masatsugu Kawashima; Haruo Watanabe; Junji Tagami; Hidenobu Senpuku
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

5.  Role of peptide antigen for induction of inhibitory antibodies to Streptococcus mutans in human oral cavity.

Authors:  Y Tsuha; N Hanada; T Asano; T Abei; S Yamaguchi; M A Salam; R Nakao; H Takeuchi; N Kurosaki; H Senpuku
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

6.  Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical Proteins.

Authors:  Benjamin J Andrick; Alexandra I Schwab; Brianna Cauley; Lauren A O'Donnell; Wilson S Meng
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.